Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for Cognitive and Mood Dysfunction in Gulf War Illness
NCT05992311Phase 1Recruiting
- Sponsor
- Baylor College of Medicine
- Start
- Aug 2025
- Primary completion
- Apr 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Gulf War syndrome (GWS) comparing Montelukast Group with Placebo Group (2 arms). Primary endpoint: Leukotriene concentration at 10 weeks. Started Aug 2025; status: recruiting.
02
Drugs
montelukast
03
Conditions
Gulf War syndrome (GWS)
Beyond the preview
Go deeper on NCT05992311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05992311.